- We are looking for a Project Manager for one of our clients in Wavre.Don't hesitate to contact me: siham.haddouchi@professionals.randstad.beConsultancy assignment: until 31/12/2024We are looking for a Project Manager for one of our clients in Wavre.Don't hesitate to contact me: siham.haddouchi@professionals.randstad.beConsultancy assignment: until 31/12/2024
- For Johnson & Johnson's Clinical Release and Stability (CRS) team, we are looking for a CRS Project Owner (scientist). The Clinical Release and Stability team is a key part of the Analytical Development department within the Discovery, Product Development & Supply (DPDS) organisation within Janssen R&D and strives to achieve a complete scientific understanding of the stability behaviour of Drug Substance (DS) and Drug Product (DP) for small molecules and nFor Johnson & Johnson's Clinical Release and Stability (CRS) team, we are looking for a CRS Project Owner (scientist). The Clinical Release and Stability team is a key part of the Analytical Development department within the Discovery, Product Development & Supply (DPDS) organisation within Janssen R&D and strives to achieve a complete scientific understanding of the stability behaviour of Drug Substance (DS) and Drug Product (DP) for small molecules and n
- For our client with a finance shared service center in Ternat, we are looking for a Project Manager Shared Service Center FinanceInterested ?Contact Eva Van den Bergh at eva.vandenbergh@professionals.randstad.be or 02/472 77 31For our client with a finance shared service center in Ternat, we are looking for a Project Manager Shared Service Center FinanceInterested ?Contact Eva Van den Bergh at eva.vandenbergh@professionals.randstad.be or 02/472 77 31
- CAR-T is an innovative treatment, which uses the power of the patient’s own immune system. A patient’s T-cells are genetically modified to eliminate cancer cells. This ground-breaking technology provides hopeful prospects to patients where other therapies have failed or fail to provide adequate results.Janssen Biotech, Inc. entered into a global collaboration agreement with Legend Biotech to develop, manufacture and commercialize ciltacabtagene autoleucelCAR-T is an innovative treatment, which uses the power of the patient’s own immune system. A patient’s T-cells are genetically modified to eliminate cancer cells. This ground-breaking technology provides hopeful prospects to patients where other therapies have failed or fail to provide adequate results.Janssen Biotech, Inc. entered into a global collaboration agreement with Legend Biotech to develop, manufacture and commercialize ciltacabtagene autoleucel
